Pregnancy category classification established regulatory framework addressing fetal exposure risk. Category A demonstrates no fetal risk in controlled trials. Category D evidence suggests fetal risk but benefits may justify use. Category X demonstrates fetal risk exceeding any benefit. Evolving classification emphasises individualized risk-benefit assessment.
Regu1atory labelling communicates pregnancy implications. Pregnancy registries monitor exposed pregnancies. Therapeutic alternatives guide provider decision-making. Patient counselling addresses pregnancy planning. Post-approval surveillance detects unexpected fetal effects.
General Biopharmaceutical Concepts
Pregnancy Category Classification
Pregnancy category classification categorises medicines according to available evidence on their potential risks and safety during pregnancy.
Continue Exploring
Browse over 900 biopharmaceutical terms across biologics, ADCs, cell & gene therapy, CMC, clinical development and manufacturing.
Browse Glossary →